Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

China flag China · Delayed Price · Currency is CNY
23.01
-0.35 (-1.50%)
At close: Feb 27, 2026
43.54%
Market Cap 22.24B
Revenue (ttm) 1.25B
Net Income (ttm) 57.48M
Shares Out 966.49M
EPS (ttm) 0.06
PE Ratio 386.92
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,313,234
Average Volume 16,210,942
Open 23.24
Previous Close 23.36
Day's Range 22.95 - 23.29
52-Week Range 15.66 - 30.20
Beta 0.37
RSI 32.30
Earnings Date Apr 22, 2026

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an... [Read more]

Sector Healthcare
Founded 1990
Employees 1,532
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000766
Full Company Profile

Financial Performance

In 2024, SHE:000766's revenue was 1.32 billion, a decrease of -10.23% compared to the previous year's 1.47 billion. Earnings were 56.44 million, an increase of 28.46%.

Financial Statements

News

There is no news available yet.